Patent details

EP2771489 Title: BIOMARKERS OF RESPONSE TO NAE INHIBITORS

Basic Information

Publication number:
EP2771489
PCT Application Number:
US2012062240
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128434164
PCT Publication Number:
WO2013063481
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BIOMARKERS OF RESPONSE TO NAE INHIBITORS
French Title of Invention:
BIOMARQUEURS DE RÉPONSE À DES INHIBITEURS DE NAE
German Title of Invention:
BIOMARKER DER REAKTION AUF NAE-INHIBITOREN
SPC Number:

Dates

Filing date:
26/10/2012
Grant date:
04/07/2018
EP Publication Date:
03/09/2014
PCT Publication Date:
02/05/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/07/2018
EP B1 Publication Date:
04/07/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2018
Expiration date:
26/10/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/06/2018
 
 

Name:
Millennium Pharmaceuticals, Inc.
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
BLAKEMORE, Stephen, J.
Address:
United States (US)

2

Name:
LI, Bin
Address:
United States (US)

3

Name:
SMITH, Peter, G.
Address:
United States (US)

4

Name:
SCHU, Matthew, C.
Address:
United States (US)

5

Name:
MULLIGAN, George, J.
Address:
United States (US)

Priority

Priority Number:
201161552686 P
Priority Date:
28/10/2011
Priority Country:
United States (US)

Classification

IPC classification:
G01N 33/50; C12Q 1/68;

Publication

European Patent Bulletin

Issue number:
201827
Publication date:
04/07/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1